Purple Biotech (PPBT) Change in Acquisitions & Divestments (2017 - 2026)
Purple Biotech (PPBT) posted quarterly Change in Acquisitions & Divestments of $2000.0 for Q1 2026, little changed year-over-year from $2000.0 in Q1 2025, and down 60.0% quarter-over-quarter from $5000.0 in Q4 2025.
Purple Biotech (PPBT) Change in Acquisitions & Divestments (2017 - 2026) Analysis & Trends
Purple Biotech (PPBT) has reported Change in Acquisitions & Divestments for 9 consecutive years, with $2000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments changed 0.0% year-over-year to $2000.0; the TTM figure through Mar 2026 stood at -$9000.0 (down 28.57% YoY), while the FY2025 annual figure was -$9000.0, down 550.0% from the prior year.
- Change in Acquisitions & Divestments fell to $2000.0 in Q1 2026 per PPBT's latest filing, from $5000.0 in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $22.1 million in Q4 2022 and bottomed at -$16.8 million in Q3 2022.
- Historically, Change in Acquisitions & Divestments has averaged $2.5 million across 5 years, with a median of $2000.0 in 2025.
- Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments slumped 1298.64% — and 2023, when it surged 100.05%.
- Purple Biotech's Change in Acquisitions & Divestments stood at $22.1 million in 2022, then slumped by 100.03% to -$6000.0 in 2023, then jumped by 50.0% to -$3000.0 in 2024, then surged by 266.67% to $5000.0 in 2025, then slumped by 60.0% to $2000.0 in 2026.
- Business Quant data shows PPBT's Change in Acquisitions & Divestments at $2000.0 in Q1 2026, $5000.0 in Q4 2025, and -$5000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Purple Biotech | 130.35 | 130.35 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Dec 31, 2023 | -6,000.00 |
| Dec 31, 2023 | -6,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 15.80 Mn |
| Mar 31, 2023 | 15.80 Mn |